Myriad Genetics MYGN Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's operating income?
- Myriad Genetics (MYGN) reported operating income of -$30.7M in Q1 2026.
- How has Myriad Genetics's operating income changed year-over-year?
- Myriad Genetics's operating income decreased by 5.9% year-over-year, from -$29M to -$30.7M.
- What is the long-term trend for Myriad Genetics's operating income?
- Over 4 years (2021 to 2025), Myriad Genetics's operating income has grown at a 19.4% compound annual growth rate (CAGR), from -$190.5M to -$387.2M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.